Versor Investments LP Cerus Corp Transaction History

Versor Investments LP

  • $623 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$1.66 - $2.42 $67,728 - $98,736
40,800 New
40,800 $77,000
Q3 2023

Nov 06, 2023
BUY
$1.5 - $3.07 $36,450 - $74,601
24,300 New
24,300 $39,000
Q1 2023

May 05, 2023
BUY
$2.65 - $3.81 $144,690 - $208,026
54,600 Added 410.53%
67,900 $201,000
Q4 2022

Jan 30, 2023
BUY
$3.38 - $4.22 $44,954 - $56,126
13,300 New
13,300 $48,000

Others Institutions Holding CERS

# of Institutions
156
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $331M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Versor Investments LP Portfolio

Follow Versor Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Versor Investments LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email